PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
November 26, 2020AIDS100 citationsOpen Access

HIV in Iran: onset, responses, and future directions

View Full Paper
SSSeyedAhmad SeyedAlinaghiIranian Institute for Health Sciences ResearchLTLeila TajSan Francisco General HospitalEMElham Mazaheri-TehraniApple (Israel)

Key Points

Key points are not available for this paper at this time.

Abstract

Iran, a country in the Middle East and North Africa (MENA) region, has been actively involved in the fight against HIV/AIDS over the past three decades. The unique features of the HIV epidemic in Iran are reflected by the modes of transmission and its recent changes to improve management and prevention programs. In this review, we recount the initial onset and subsequent spread of HIV infection in Iran, beginning with the first case diagnosed to the ongoing responses and most recent achievements in controlling this epidemic. Although in the MENA region, Iran is one of the pioneers in implementing pertinent policies including harm reduction services to decrease HIV incidence, drug injection still continues to be the major risk of infection. In line with other nations, the programs in Iran aim at the UNAIDS 90-90-90 targets (UNAIDS 90-90-90 global targets to end the AIDS epidemic by 2020: by 2020, 90% of all people living with HIV will know their HIV status; 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy; and 90% of all people receiving antiretroviral therapy will have viral suppression) and to eliminate mother-to-child HIV transmission. In this article, we discuss the strengths and shortcomings of the current HIV programs and offer suggestions to provide a better perspective to track and respond to the HIV epidemic. More generally, our account of the national religious and cultural circumstances as well as obstacles to the approaches chosen can provide insights for decision-makers in other countries and institutions with comparable settings and infrastructures.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

SeyedAlinaghi et al. (2020) studied this question.

synapsesocial.com/papers/69dd3f7f7d97b7e86940c6a8https://doi.org/10.1097/qad.0000000000002757
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prevalence of HIV, HBV and HCV among street and labour children in Tehran, Iran2016 · 45 citations
  2. 2Primary Health Care Strategic Key to Control HIV/AIDS in Iran2013 · 7 citations
  3. 3Integration of HIV Services into Primary Health Care (PHC) System2016 · 1 citations